Monrovia, CA, March 14, 2010 --(PR.com
)-- Katy Spink, Vice President of Operations for Geron, will give the Featured address entitled “GRNCM1: Human Embryonic Stem Cell Derived Cardiomyocytes for the Treatment of Heart Failure” at GTCbio’s 6th Annual Stem Cell Research & Therapeutics Conference on May 27-28, 2010 in Boston, MA.
Dr. Spink will discuss Geron’s GRNCM1 program, in which they are developing hESC-derived cardiomyocytes for the treatment of heart failure, including methods for high efficiency differentiation of cardiomyocytes from hESCs, characterization of the resulting cell population, preclinical data on cellular function, and next steps for the development of this product towards the clinic.
Other notable presenters at the conference include Rudolf Jaenisch, Ph.D, Founding Member of The Whitehead Institute and Professor of Biology at the Massachusetts Institute of Technology and Tracey Lodie, Director of Stem Cell Biology at Genzyme.
GTCbio's 6th annual conference on Stem Cell Research and Therapeutics provides stem cell researchers with a comfortable environment to exchange ideas and brainstorm on novel pathways to discovery. Leading experts in the field will present unreleased information and attendees will learn the most up-to-date developments in this arena. For more information visit http://gtcbio.com/conferenceDetails.aspx?id=145.